BannerBio Nutraceuticals Inc.

BannerBio Nutraceuticals Inc. is dedicated in the research, development and sales of botanical bioactive ingredients and sports nutrition ingredients.

    BannerBio has been focusing on R&D since its initiation. Over these years, BannerBio has owned several patents and technology trademarks such as ActXTract™ (Botanical Extraction Technology) and NanoEncaps™ (Microencapsulation technology). It has also developed several product trademarks: GriffsTract® (Griffonia Seed Extract), GrapsTract® (Grape Seed Extract) and OlfsTract® (Olive Leaf Extract).

    BannerBio has a well-established quality system. Our lab is equipped with Waters HPLC, Agilent HPLC, ELSD, GC, UV, laser particle size analyzer, etc. Our quality team is consisted of experienced and professional personnel so as to make our quality system runs efficiently.

    BannerBio has two manufacturing facilities and a new factory under construction. Our manufacturing facilities are cGMP and Kosher certified. The new factory is expected to start production since the end of 2015.

    BannerBio’s major products include: Griffonia Seed Extract, Grape Seed Extract, Olive Leaf Extract, Pine Bark Extract, Mulberry Leaf Extract, iBCAA, granular BCAA, instant-Leucine, etc. BannerBio also provides OEM services such as micronizing, granulation and microencapsulation.

GrapsTract® is a branded product of superior quality manufactured by BannerBio’s patented technology. Initiated by BannerBio, the research of GrapsTract® on anti-Alzheimer’s Disease has made some new progresses.

     According to the researcher, GrapsTract® can significantly elevate the activity of Aβ_25-35  induced PC12 cell injury, increase mitochondria membrane potential and reduce the content of extracellular L-lactate dehydrogenase (LDH). Meanwhile, APP/PPS1 double-transgenic rats showed significant differences after GrapsTract® administration. The group of rats administered by GrapsTract® demonstrated shortened escape response latency and improved learning capability in Morris water maze and space exploration experiments, compared to control group. Analysis of the chromosomes pattern in the rats’ hippocampal tissue showed that GrapsTract® administered rats had less orange-red plaques in hippocampal tissue in terms of quantity and area. These results suggest that GrapsTract® can effectively reduce the production of Aβand improve learning capability of AD affected rats.